Niraparib |
Niraparib : Inhibitor of PARP1 and PARP2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PARP1 |
|
|
| PARP2 |
|
|
Inhibitor
Up to 50 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - TNKS 570 nM, PARP3 296 nM, PARP4 446 nM, PARP12 79 nM
Potency Assay Off-Target:
In TCA precipitation assays, MK-4827 was at least 300-fold selective for PARP1 and PARP2 over TNKS, ...
Selectivity Assessment Description:
In TCA precipitation assays, MK-4827 was at least 300-fold selective for PARP1 and PARP2 over TNKS, ...
Potency Cellular
In Vitro
PARP1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm901188v
PARP2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm901188v
In Vivo Validations
Rat, mouse
Dose:
Route of delivery:
Intravenous
Plasma half life:
3.4 hr (rat)
Systemic clearance:
28 mL/min/kg (rat)
Organ of interest (O):
MDA-MB-436 xenograft
Target engagement assay:
Not available
DOI Reference: 10.1021/jm901188v
Chemical Information
| Molecular Formula | C19H20N4O |
| SMILEs | NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 |
| InChI | InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1 |
| Molecular weight | 320.16 Da |
| AlogP | 2.591400000000001 |
| HBond acceptors | 5 |
| HBond donors | 3 |
| Atoms | 44 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.